I don’t agree in a buy-out. You give up so much

New Post Public Reply Private Reply Replies (0) Message Board
Goosebumps JLang #68051
751
I don’t agree in a buy-out. You give up so much potential. We as investors don’t need the help and we will cross that finish line. For me... that is happening as we speak behind the scenes as we don’t know what is happening and Cytodyn can’t divulge everything if the government is somehow involved behind the scenes with an approval. Myself I believe they are aware of where we are. Take the Medicare and Medicaid billing numbers by name written in for Cytodyn. This is only a little smoke but has some creative thinking possibly going on that we don’t know about.

At this point we don’t need a buy out to further our process. We are on the cusp of greatness and it would only reduce our investment to share the potential with another pharmaceutical company by selling out. I am not a proponent of a fast nickel when a slow dime is just around the corner. I don’t believe it’s going to be a slow dime either is going to be a wind fall of dimes... giving up a potential of something amazing like Vyrologix is like giving up an early stock like Microsoft or Apple and taking a few thousand dollars for what could be millions of dollars.

To me... I look at inflammation as the single worst symptom of most diseases and what does Leronlimab do? Reduce inflammation. How does this happen? It stops the inflammation by stopping the immune response. So we have an amazing drug that regulates the immune system and stops the immune system from attacking the victim and does this all with unmatched safety. When you look at the action of this little molecule. You have to see that this method of action could very well work for many diseases. Stopping them cold in their tracks. With all this potential I will wait for the best return an investor can hope for. The new Amazon type investment is Cytodyn. 3-5 years from now... we will all be laughing at the thought of what if... what if we would of sold out or been bought out. When we are traveling the world with all the money from our Vyrologix investment that helped Vyrologix help to make the world become a Safe place again. Especially if we become a vaccine booster to lengthen the time of vaccine that might only be good for 6 months or so. Covid could be huge for us if that happen. But even if it doesn’t. There are many ways looking forward that you can see this drug being a blockbuster for not just one indication. But for many blockbuster indications. Call me greedy... I don’t want to share that with other big pharmaceutical companies when we don’t have to. We are on the cusp of something great. But that’s just my opinion. You others can have your opinions. It wouldn’t take away from my beliefs and I will hold Vyrologix for that 3-5 years and still keep a large share invested forever.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

See's Candies Data Breach Spurs Legal Scrutiny

Updated Category News Views 13

Data Breach Hits See's Candies Hard Amidst Ransomware Attack Alright, folks, here's a not-so-sweet tale to kick off your day — See's Candies has found itself in a bit of a pickle. A ransomware attack, the nasty kind that makes you double-check your locks and your passwords, has reportedly exposed the personal data of its customers and employees. We're talking names,...

Continue Reading
Asia-Pacific Media Forum Eyes Future Growth Strategies

Updated Category News Views 3

Media Heavyweights Converge in Shenzhen Picture this: Over 400 media moguls from the Asia-Pacific region, huddled together in Shenzhen under that blazing September sun. What for? They're on a mission, inspecting China's shifting landscape, hunting down fresh growth avenues in the Guangdong-Hong Kong-Macao Greater Bay Area. It kicks off within the walls of the Asia-Pacific...

Continue Reading
Ice-Rock Avalanches: Future Risks and Urgent Lessons

Updated Category News Views 2

Mounting Threats in Mountain Chains That nightmare on August 26 at Mount Langtang Lirung in Nepal—where an ice-rock avalanche triggered a catastrophic mudslide—brought a harsh reminder that these mountains are cracking wide open. With 31 dead and over 500 souls still unaccounted for, it's a chilling warning about how vulnerable high-altitude regions have become. A...

Continue Reading
D-Wave Hit with Legal Scrutiny After Disappointing Q2

Updated Category News Views 4

D-Wave Quantum Under Legal Microscope Alright, folks, let's dive headfirst into some dicey financial waters with D-Wave Quantum Inc. (NASDAQ: QBTS). This quantum computing company is finding itself in a bit of a pickle following some rough second-quarter results that left investors scratching their heads. If you bought into the hype and are feeling the sting in your...

Continue Reading
Midea's VitaBreeze: Revolutionizing Personalized Climate

Updated Category News Views 7

A Fresh Breeze in Climate Control Here's something that'll shake up your household. Midea just announced their latest gizmo, called VitaBreeze, and they’re not messing around. They introduced it at IFA 2026, promising it's not just for cooling off in the summer or heating in the winter. Oh no, my friends, they've packed this unit with enough cutting-edge tech that...

Continue Reading
Changhong's IFA 2026 Showcase: AI, Culture & Localization

Updated Category News Views 4

Changhong's Game Plan: From Global Reach to Local Touch Well, Changhong's not sitting back at IFA 2026, let me tell you that. This isn't your run-of-the-mill showcase; it's a full-on reveal of what happens when a company takes AI tech and tunes it to the heartbeat of daily life. TVs, fridges, air conditioners—you name it, they've got an AI twist on it. But is this just...

Continue Reading
Global Movement Urges Dr. Hak Ja Han's Release

Updated Category News Views 3

Under the shadows of Manhattan's skyline, something more than a regular service took shape. The New Yorker Hotel hosted an impassioned gathering of the Family Federation for World Peace and Unification. These folks weren't just saying their prayers; they were making a call—loud and resonant—for the release of Dr. Hak Ja Han. The Power of Collective Voices Gathering in...

Continue Reading
XiamenAir Takes Off with Fujian-London Link

Updated Category News Views 2

A New Dawn for Fujian Travelers Here's a nugget to chew on: XiamenAir's first-ever direct flight from Xiamen to London had its moment in the spotlight. This isn't just another intercontinental flyby—it's a game-changer for folks in Fujian looking to hop across the pond without the layover hassle. With Flight MF821 touching down in Heathrow early on September 6th, this...

Continue Reading
Zendure, SolarFlow Pro Win Big at IFA 2026 Tech Awards

Updated Category News Views 2

Trophy Time for Zendure in Berlin The Berlin Chronicles of 2026 tell an interesting tale for Zendure—a tale where top honors and glowing recognition highlight its efforts in the sustainable energy arena. At the Global Product Technology Innovation Awards, Zendure's SolarFlow 4000 Mix Pro snagged the Gold for Sustainable Home Energy Storage System. Not only that, but...

Continue Reading

Top 5 Most Recently Viewed Articles

Top Chip Stocks Set for Growth with Rising AI Demand

Updated Category News Views 229

Emerging Semiconductor Industry Trends The rapid adoption of artificial intelligence is transforming the semiconductor industry. As businesses increasingly rely on advanced technologies, the demand for semiconductors has surged dramatically. This has led to significant developments in the stock market, particularly for companies involved in chip manufacturing and...

Continue Reading
dsm-firmenich Outlines Progress on Share Buyback Strategy

Updated Category News Views 294

Overview of Share Repurchase Program dsm-firmenich, a leader in nutrition, health, and beauty innovation, recently embarked on an ambitious share repurchase program aimed at enhancing shareholder value. This initiative commenced with a plan to repurchase ordinary shares worth €1 billion, with the first tranche set at €500 million. Details of the Implementation The...

Continue Reading
80 Acres Farms Boosts Nationwide Microgreens Availability

Updated Category News Views 159

80 Acres Farms Expands Microgreens Nationwide As consumer preferences shift towards healthier food options, 80 Acres Farms is stepping up to meet the growing demand for fresh produce. The company's initiative to expand its microgreens reach across supermarkets in the United States is a clear indicator of the booming interest in these nutritious greens. Strengthening...

Continue Reading
Upexi's Allan Marshall Boosts Stake with $310K Purchase

Updated Category News Views 82

Insights into Allan Marshall's Stock Purchase Allan Marshall, the Chief Executive Officer of Upexi (NASDAQ: UPXI), recently disclosed a significant insider purchase that has caught the attention of investors and analysts alike. This purchase reflects a bullish sentiment towards the company’s future prospects and symbolizes a strong vote of confidence from its...

Continue Reading
OpenFortune and Reflekta Partner for an Innovative Campaign

Updated Category News Views 146

Innovative Partnership Between OpenFortune and Reflekta Emotional AI Meets Fortune Cookie to Spark a New Kind of Legacy Conversation OpenFortune, recognized as the leading fortune cookie media network globally, has announced an exciting collaboration with Reflekta, an innovative platform dedicated to transforming memories into interactive digital legacies. This...

Continue Reading